Come up with a name for your new list and we'll add to it:
Crucell raised a round of funding on October 06, 2010. Investors include
Johnson & Johnson.
Crucell (Euronext, NASDAQ: CRXL; Swiss Exchange: SW CRX) is a biotechnology company focused on research, development and worldwide marketing of vaccines and antibodies that prevent and treat infectiou…